Request Sample Inquiry
Digital PCR (dPCR) and Real-Time PCR (qPCR) Market

Digital PCR (dPCR) and Real-Time PCR (qPCR) Market

Digital PCR (dPCR) and Real-Time PCR (qPCR) Market - Global Industry Assessment & Forecast

Number Of Pages # Pages:

140

Base Year:

2021

Date

Aug - 2022

Format:

PDF XLS PPT

Report Code:

VMR-1370

Segments Covered
  • By Product & Service qPCR Products & Services, qPCR Reagents & Consumables, qPCR Instruments, qPCR Software & Services, dPCR Products & Services, dPCR Instruments, dPCR Reagents & Consumables, dPCR Software & Services
  • By Application qPCR Applications, Clinical Applications, Research Applications, Forensic Applications, dPCR Applications
  • By End User qPCR End Users, Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Clinical Research Organizations, Pharmaceutical & Biotechnology Companies, Forensic Laboratories
  • By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Forecast YearsForecast Years: 2022 - 2028
Historical YearsHistorical Years: 2016 - 2021
Revenue 2021Revenue 2021: 5,341.60 USD Million
Revenue 2028Revenue 2028: 8,860.22 USD Million
Revenue CAGRRevenue CAGR (2022 - 2028): 8.8%
Fastest Growing Region Fastest Growing Region (2022 - 2028) Asia Pacific
Largest Region Largest Region (2021): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report
  • Go To Market Strategy
  • Region Specific Market Dynamics
  • Region Level Market Share
  • Import Export Analysis
  • Production Analysis
  • Others Request Customization Speak To Analyst
Digital PCR (dPCR) and Real-Time PCR (qPCR) Market Share

Market Synopsis:

Digital dPCR and (qPCR) Market was valued at 5,341.60 USD Million in 2021 and is projected to reach a value of 8,860.22 USD Million by 2028 and is expected to grow at a Compound Annual Growth Rate (CAGR) of 8.8% over the forecast period.

The growing market penetration in the emerging countries and shifting of consumers' opinions from plant-delivered drugs to genome-based drugs are projected to boost the market growth during the forecast period. Growth in the occurrence of target diseases globally attached with the verified efficiency of Digital PCR (dPCR) and Real-Time PCR (qPCR) analysis in the diagnosis and the valuation of disease-causing microbes, which will drive the utilization of clinical diagnostic tests including Digital PCR (dPCR) and Real-Time PCR (qPCR) analysis which is expected to contribute to the growth of the market during the forecast period. The rising technological advancements in PCR technologies, growing investments, funds, and grants are expected to increase the demand for Digital PCR (dPCR) in the upcoming years. Moreover, the rising incidents of genetic disorders, target infectious diseases, increasing use of biomarker profiling for disease diagnostics, and the successful completion of the Human Genome Project are the major factors driving the growth of the Digital PCR (dPCR) and Real-Time PCR (qPCR) Market during the forecast period. Furthermore, the transition of the plant to genome-based drug discovery is expected to offer the opportunity for the growth of the digital PCR (dPCR) and Real-Time PCR (qPCR) Market in the upcoming years. Additionally, the technical limitations related to PCR and the increased cost of PCR devices are projected to hinder the growth of the Digital PCR (dPCR) and Real-Time PCR (qPCR) market during the forecast period.

Digital PCR (dPCR) and Real-Time PCR (qPCR) Market Size, 2021 To 2028 (USD 8,860.22 Million)

Market Segmentation:

The Digital PCR (dPCR) and Real-Time PCR (qPCR) Market is segmented based on Product & Services, Application, End-User, and Region. Based on Product & Services, the market is further segmented into qPCR Products & Services, qPCR Reagents & Consumables, qPCR Instruments, qPCR Software & Services, dPCR Products & Services, dPCR Instruments, dPCR Reagents & Consumables, and dPCR Software & Services. Furthermore, based on Application, the market is segmented as qPCR Applications, Clinical Applications, Research Applications, Forensic Applications, dPCR Applications, Clinical Applications, Research Applications, and Forensic Applications. In addition, based on End-Users, the market is segmented as qPCR End User, Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Clinical Research Organizations, Pharmaceutical & Biotechnology Companies, and Forensic Laboratories.

Below tree is interactive. You can click the nodes to get more information.

The Hospital & Diagnostic Centers acquires the largest share of the Digital PCR (dPCR) and Real-Time PCR (qPCR) Market

The Hospital & Diagnostic Center segment is expected to dominate the Digital PCR (dPCR) and Real-Time PCR (qPCR) Market during the forecast period owing to the increasing availability of qPCR reagents in the market. In the Application of clinical diagnostic, and the ongoing expansion of healthcare infrastructure across emerging countries. The high prevalence and incidence of target diseases like HIV-AIDS, Cancer, malaria, and tuberculosis are expected to increase the demand for hospital and diagnostic centers in the Digital PCR (dPCR) and Real-Time PCR (qPCR) market. The increasing awareness among End-Users associated with the benefits provided by qPCR ineffective and rapid disease diagnosis is expected to drive the Digital PCR (dPCR) and Real-Time PCR (qPCR) Market growth in coming years.

The Clinical segment of dPCR is projected to grow at the highest CAGR during the Forecast Period

The clinical segment is expected to grow at the highest Compound Annual Growth Rate (CAGR) during the forecast period. The growth of the clinical segment is primarily attributed to the better precision, increased device sensitivity, and complete qualification of the target molecule. The increasing adoption of dPCR among Hospital & Diagnostic Centers and increasing cases of AIDS and cancer are expected to increase the demand for dPCR in the coming years.

North America is projected to hold the largest share of Digital PCR (dPCR) and Real-Time PCR (qPCR) during the forecast period

The growth in the North American Digital PCR (dPCR) and Real-Time PCR (qPCR) Market is mainly attributed to the increasing adoption of advanced and original genomic analysis products including innovative Digital PCR (dPCR) and Real-Time PCR (qPCR) products. The growth in the availability of Research and Development (R&D) funding for genomic research connected with the robust research infrastructure available in the region is increasing the growth of the Digital PCR (dPCR) and Real-Time PCR (qPCR) market in North America. North America is growing due to the early commercialization of Digital PCR (dPCR) and Real-Time PCR (qPCR) products as compared with the other regions. The North American region including Canada and the United Kingdom is projected to be the largest market owing to the increased funding for Digital PCR (dPCR) and Real-Time PCR (qPCR) technologies.

Asia Pacific region is projected to grow at the highest Compound Annual Growth Rate (CAGR) owing to rapidly developing economies, a rise in the government support for life science research, growth in the aging population connected with the growth in the incidence of genetic diseases, growing research, and the clinical trial out-sourcing from the region which is expected to increase the demand of Digital PCR (dPCR) and Real-Time PCR (qPCR) in the Asia Pacific region.

Competitive Landscape:

The key players in the Global Digital PCR (dPCR) and Real-Time PCR (qPCR) Market include- Thermo Fisher Scientific (US), Bio-Rad Laboratories Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Abbott Laboratories (US), Agilent Technologies (US), Analytik Jena AG (Germany), Becton, Dickinson and Company (US), bioMérieux SA (France), Danaher Corporation (US), Eppendorf (Germany), Fluidigm Corporation (US), Merck KGaA (Germany), QIAGEN N.V. (German), Takara Bio (Japan), Meridian Bioscience (US), Promega Corporation (US), Enzo Life Sciences, Inc. (US), Bioneer (South Korea), ELITech Group (France), Quidel Corporation (US) and others.

Segmentation of the Global Digital PCR (dPCR) and Real-Time PCR (qPCR) Market:

Parameter Details
Segments Covered
  • Product & Service (qPCR Products & Services, qPCR Reagents & Consumables, qPCR Instruments, qPCR Software & Services, dPCR Products & Services, dPCR Instruments, dPCR Reagents & Consumables, dPCR Software & Services)
  • Application (qPCR Applications, Clinical Applications, Research Applications, Forensic Applications, dPCR Applications)
  • End User (qPCR End Users, Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Clinical Research Organizations, Pharmaceutical & Biotechnology Companies, Forensic Laboratories)
  • Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa)
Regions & Countries Covered
  • North America - (U.S., Canada, Mexico)
  • Europe - (U.K., France, Germany, Italy, Spain, Rest Of Europe)
  • Asia Pacific - (China, Japan, India, South Korea, South East Asia, Rest Of Asia Pacific)
  • Latin America - (Brazil, Argentina, Rest Of Latin America)
  • Middle East & Africa - (GCC Countries, South Africa, Rest Of Middle East & Africa)
Companies Covered
  • Thermo Fisher Scientific (US)
  • Bio-Rad Laboratories Inc. (US)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Abbott Laboratories (US)
  • Agilent Technologies (US)
  • Analytik Jena AG (Germany)
  • Becton
  • Dickinson and Company (US)
  • bioMérieux SA (France)
  • Danaher Corporation (US)
  • Eppendorf (Germany)
  • Fluidigm Corporation (US)
  • Merck KGaA (Germany)
  • QIAGEN N.V. (German)
  • Takara Bio (Japan)
  • Meridian Bioscience (US)
  • Promega Corporation (US)
  • Enzo Life Sciences Inc. (US)
  • Bioneer (South Korea)
  • ELITech Group (France)
  • Quidel Corporation (US)
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, technology landscape, patent analysis, market attractiveness analysis by segments and North America, company market share analysis, and COVID-19 impact analysis

Digital PCR (dPCR) and Real-time PCR (qPCR) Market to Reach Valuation of 8,860.22 USD Million by 2028; Increase in Incidence of Targeted Infectious Diseases & Genetic Disorders is Fuelling the Demand for the Digital PCR (dPCR) and Real-time PCR (qPCR) Market
In terms of revenue, the Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market is expected to reach 8,860.22 USD Million by 2028, growing at a CAGR of 8.80% from 2022 to 2028. Increasing incidence & prevalence of genetic & infectious diseases; technological advancement in PCR; and rising numbe...
FAQ
Frequently Asked Question
  • The global Digital PCR (dPCR) and Real-Time PCR (qPCR) valued at 5,341.60 USD Million in 2020 and is expected to reach 8,860.22 USD Million in 2028 growing at a CAGR of 8.8%.

  • The prominent players in the market are Thermo Fisher Scientific (US), Bio-Rad Laboratories Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Abbott Laboratories (US), Agilent Technologies (US), Analytik Jena AG (Germany), Becton, Dickinson and Company (US), bioMérieux SA (France), Danaher Corporation (US), Eppendorf (Germany), Fluidigm Corporation (US), Merck KGaA (Germany), QIAGEN N.V. (German), Takara Bio (Japan), Meridian Bioscience (US), Promega Corporation (US), Enzo Life Sciences, Inc. (US), Bioneer (South Korea), ELITech Group (France), Quidel Corporation (US).

  • The market is project to grow at a CAGR of 8.8% between 2021 and 2028.

  • The driving factors of the Digital PCR (dPCR) and Real-Time PCR (qPCR) include

    • Growing market penetration in the emerging countries and shifting of consumers' opinions from plant-delivered drugs to genome-based drugs.

  • North America was the leading regional segment of the Digital PCR (dPCR) and Real-Time PCR (qPCR) in 2020.